Naz Rahman

Stock Analyst at Maxim Group

(0)
# 4870
Out of 5,320 analysts
51
Total ratings
17.65%
Success rate
-29.78%
Average return
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
GLMD Galmed Pharmaceutica...
Downgrades: Hold
n/a
n/a n/a 1 Apr 4, 2025
NVCT Nuvectis Pharma
Initiates Coverage On: Buy
17
8.34 103.84% 1 Apr 2, 2025
SLXN Silexion Therapeutic...
Maintains: Buy
9 5
0.72 594.44% 2 Mar 20, 2025
SCPH scPharmaceuticals
Maintains: Buy
20 12
2.56 368.75% 3 Mar 20, 2025
VKTX Viking Therapeutics
Maintains: Buy
120 70
23.7 195.36% 5 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 4 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 8
0.71 1026.76% 7 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
0.59 408.47% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Mar 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
525 140
5.66 2373.5% 2 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.04 9900% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
1.03 385.44% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 May 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
2.65 126.42% 1 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
14.7 83.67% 1 Mar 31, 2021